Garheng Kong M.D., Ph.D.

Garheng Kong has served as a director of the Company since December 1, 2013 and Lead Independent Director since June 2023. Dr. Kong also serves as the Chair of the Nominating and Corporate Governance Committee for the Company. Dr. Kong is the managing partner of HealthQuest Capital, a healthcare-focused investment firm, a role he has held since he founded HealthQuest Capital in 2012. He was previously a general partner at Sofinnova Investments, a healthcare investment firm, a position he held from 2010 to 2013. Before joining Sofinnova, Dr.

Kirsten M. Kliphouse

Kirsten M. Kliphouse has served as a director of the Company since October 12, 2022. Ms. Kliphouse previously served as the President of Google Cloud Americas, a public cloud vendor that offers a suite of computing services, a position she held from March 2022 to June 2023, where she was responsible for leading and growing the sales, go-to-market, customer engagement, channel, and services organizations. At Google Cloud, she also served as the Global Chair of the Aspiring Leadership Academy and Women@Google Cloud. Prior to her position as President, Ms.

D. Gary Gilliland M.D., Ph.D.

D. Gary Gilliland has served as a director of the Company since April 1, 2014. Dr. Gilliland has served as President and Director Emeritus of the Fred Hutchinson Cancer Research Center, a research organization, in Seattle, WA since January 2020. From January 2015 to January 30, 2020, Dr. Gilliland served as President and Director of the Fred Hutchinson Cancer Research Center.

Jeffrey A. Davis

Jeffrey A. Davis has served as a director of the Company since December 1, 2019, and Chairman of the Audit Committee since June 2023. Mr. Davis previously served as the Chief Financial Officer of Dollar Tree, Inc. from October 2022 through March 2025. Prior to his time at Dollar Tree, Inc., Mr. Davis served as Chief Financial Officer of Qurate Retail Group, a leading retailer and media conglomerate comprised of eight retail brands including QVC, HSN and Zulily, from October 2018 through August 2022. Prior to Qurate Retail Group, Mr.

Kerrii B. Anderson

Kerrii B. Anderson has served as a director of the Company since May 17, 2006. Ms. Anderson is the former Chief Executive Officer, President and Chief Financial Officer of Wendy’s International. Prior to joining Wendy’s in 2000, she was senior vice president and chief financial officer for 14 years for M/I Homes, Inc., a public company that builds single-family homes.

Sandy van der Vaart

Sandy van der Vaart has served as Executive Vice President, Chief Legal Officer and Corporate Secretary of Labcorp since February 2020.

Megan Bailey

Megan Bailey has served as Labcorp’s Executive Vice President and President, Central Laboratory Services and International since 2024. 

Previously, she served as Labcorp’s Executive Vice President and Chief Strategy and Transformation Officer where she led efforts to define Labcorp’s future growth strategy.

Mark Schroeder

Mark Schroeder has served as Labcorp’s Executive Vice President and President, Diagnostics and Chief Operations Officer since 2023. 

In this role, Mark leads all Diagnostics divisions and commercial teams, as well as routine and esoteric testing laboratory operations for Labcorp Diagnostics and global supply chain.

Lance Berberian

In October 2024, Lance Berberian announced his planned retirement from Labcorp in 2025. Lance served as Executive Vice President and Chief Information and Technology Officer from 2014 through October 2024. In November 2024, he stepped into the role of Special Advisor, Strategy. In this role he is working directly with the CEO and the executive team to drive the development and implementation of Labcorp’s enterprise strategy.

Glenn A. Eisenberg

In November 2024, Glenn Eisenberg announced his planned retirement from Labcorp, effective April 30, 2025. Glenn served as Executive Vice President and Chief Financial Officer (CFO) since 2014. In December 2024, Glenn assumed the role as Special Advisor to the CEO to ensure a seamless transition of his current role and assist with strategic initiatives underway within the company.